Immunovant (IMVT) EBIT (2018 - 2026)
Immunovant (IMVT) reported EBIT of -$153.22 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$119.7 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) EBIT (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunovant's EBIT came in at -$538.92 million; for FY2026 (ended Mar 31, 2026), it was -$505.39 million.
- By fiscal year, EBIT came in at -$412.95 million in FY2025, -$258.77 million in FY2024, -$210.95 million in FY2023 and -$156.81 million in FY2022.
- The fiscal Q1 2027 figure ranks as the lowest quarterly EBIT in data going back to fiscal Q3 2019.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$150.7 million (Q4 2026), -$109.08 million (Q3 2026) and -$125.91 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Immunovant | 5.85 Bn | 2.63 Bn | - | -153.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -153.22 Mn |
| Mar 31, 2026 | -150.70 Mn |
| Dec 31, 2025 | -109.08 Mn |
| Sep 30, 2025 | -125.91 Mn |
| Jun 30, 2025 | -119.70 Mn |
| Mar 31, 2025 | -105.87 Mn |
| Dec 31, 2024 | -110.97 Mn |
| Sep 30, 2024 | -109.04 Mn |
| Jun 30, 2024 | -87.07 Mn |
| Mar 31, 2024 | -75.09 Mn |
| Dec 31, 2023 | -51.53 Mn |
| Sep 30, 2023 | -58.21 Mn |
| Jun 30, 2023 | -73.95 Mn |
| Mar 31, 2023 | -60.42 Mn |
| Dec 31, 2022 | -62.84 Mn |
| Sep 30, 2022 | -47.67 Mn |
| Jun 30, 2022 | -40.02 Mn |
| Mar 31, 2022 | -47.18 Mn |
| Dec 31, 2021 | -41.39 Mn |
| Sep 30, 2021 | -37.73 Mn |
API Access
Immunovant EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();